PD Dr. Arnd Kleyer

Lehrstuhl für Innere Medizin III Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial (2021) Mucke J, Knitza J, Muehlensiepen F, Grahammer M, Stenzel R, Simon D, Kleyer A, et al. Journal article Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students (2021) Knitza J, Tascilar K, Gruber E, Kaletta H, Hagen M, Liphardt AM, Schenker H, et al. Journal article Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial (2021) Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Morf H, et al. Journal article Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs (2021) Vodencarevic A, Tascilar K, Reiser M, Hueber A, Haschka J, Bayat S, Meinderink T, et al. Journal article Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis (2021) Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G Journal article Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease (2021) Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, et al. Journal article Virtual teaching for medical students during SARS-CoV-2 pandemic (2021) Pfeil A, Franz M, Hoffmann T, Klemm P, Oelzner P, Muller-Ladner U, Lange U, et al. Journal article, Letter Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial (2021) Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber A, Manger B, et al. Journal article Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis (2021) Valor-Méndez L, Kleyer A, Schett G, Manger B, Sticherling M Journal article